Tags

Type your tag names separated by a space and hit enter

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Abstract

INTRODUCTION

The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association.

METHODS

The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document.

RESULTS

The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC.

CONCLUSIONS

The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    1Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

    ,

    2Department of Pathology, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

    ,

    3Department of General, Visceral, and Vascular Surgery, University Hospital, University of Halle-Wittenberg, Halle/Saale, Germany.

    ,

    4Department of Endocrinology, University of Pisa, Pisa, Italy.

    ,

    5Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.

    ,

    6Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

    ,

    7Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.

    ,

    3Department of General, Visceral, and Vascular Surgery, University Hospital, University of Halle-Wittenberg, Halle/Saale, Germany.

    ,

    8Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

    ,

    9Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Siena, Italy.

    ,

    10Endocrine Practice, Moleculargenetic Laboratory, Medical Faculty, University of Heidelberg, Heidelberg, Germany.

    ,

    10Endocrine Practice, Moleculargenetic Laboratory, Medical Faculty, University of Heidelberg, Heidelberg, Germany.

    ,

    11University of Sydney School of Medicine, Sydney, New South Wales, Australia.

    ,

    12Departments of Internal Medicine, Pediatrics and Behavioral Science, University of Kentucky, Lexington, Kentucky.

    ,

    13Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita' di Napoli "Federico II," Napoli, Italy.

    ,

    14Institut Gustave Roussy, Service de Medecine Nucleaire, Université of Paris-Sud, Villejuif, France.

    ,

    15Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.

    ,

    6Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

    Source

    MeSH

    Antineoplastic Combined Chemotherapy Protocols
    Biopsy, Fine-Needle
    Carcinoma, Medullary
    Carcinoma, Neuroendocrine
    Disease Management
    Genetic Testing
    Hormone Replacement Therapy
    Humans
    Multiple Endocrine Neoplasia Type 2a
    Multiple Endocrine Neoplasia Type 2b
    Proto-Oncogene Proteins c-ret
    Radiotherapy
    Societies, Medical
    Thyroid Neoplasms
    Thyroidectomy

    Pub Type(s)

    Journal Article
    Practice Guideline
    Review

    Language

    eng

    PubMed ID

    25810047

    Citation

    Wells, Samuel A., et al. "Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma." Thyroid : Official Journal of the American Thyroid Association, vol. 25, no. 6, 2015, pp. 567-610.
    Wells SA, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567-610.
    Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., ... Waguespack, S. G. (2015). Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association, 25(6), pp. 567-610. doi:10.1089/thy.2014.0335.
    Wells SA, et al. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 2015;25(6):567-610. PubMed PMID: 25810047.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. AU - Wells,Samuel A,Jr AU - Asa,Sylvia L, AU - Dralle,Henning, AU - Elisei,Rossella, AU - Evans,Douglas B, AU - Gagel,Robert F, AU - Lee,Nancy, AU - Machens,Andreas, AU - Moley,Jeffrey F, AU - Pacini,Furio, AU - Raue,Friedhelm, AU - Frank-Raue,Karin, AU - Robinson,Bruce, AU - Rosenthal,M Sara, AU - Santoro,Massimo, AU - Schlumberger,Martin, AU - Shah,Manisha, AU - Waguespack,Steven G, AU - ,, PY - 2015/3/27/entrez PY - 2015/3/27/pubmed PY - 2016/2/26/medline SP - 567 EP - 610 JF - Thyroid : official journal of the American Thyroid Association JO - Thyroid VL - 25 IS - 6 N2 - INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. METHODS: The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document. RESULTS: The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC. CONCLUSIONS: The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice. SN - 1557-9077 UR - https://www.unboundmedicine.com/medline/citation/25810047/full_citation L2 - https://www.liebertpub.com/doi/full/10.1089/thy.2014.0335?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -